Revised enoxaparin label to provide more information regarding use in patients with mechanical prost
Bridgewater, NJ - The FDA has approved a supplemental new drug application (sNDA) regarding the use of enoxaparin (Lovenox ®, Aventis) antithrombotic therapy in patients with mechanical prosthetic ...
With new federal agency officials coming in with the new administration, food manufacturers are jumping on the opportunity to push for a four-year delay of the revised Nutrition Facts label. The Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results